CH665355A5 - Pharmazeutische zusammensetzung. - Google Patents
Pharmazeutische zusammensetzung. Download PDFInfo
- Publication number
- CH665355A5 CH665355A5 CH3039/85A CH303985A CH665355A5 CH 665355 A5 CH665355 A5 CH 665355A5 CH 3039/85 A CH3039/85 A CH 3039/85A CH 303985 A CH303985 A CH 303985A CH 665355 A5 CH665355 A5 CH 665355A5
- Authority
- CH
- Switzerland
- Prior art keywords
- warm
- purified
- blooded animals
- mice
- endotoxin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/630,013 US4629722A (en) | 1984-07-12 | 1984-07-12 | Method of inhibiting the onset of acute radiation syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH665355A5 true CH665355A5 (de) | 1988-05-13 |
Family
ID=24525404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH3039/85A CH665355A5 (de) | 1984-07-12 | 1985-07-12 | Pharmazeutische zusammensetzung. |
Country Status (14)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4866034A (en) * | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
| US5354782A (en) * | 1991-01-17 | 1994-10-11 | Merrell Dow Pharmaceuticals Inc. | Polyamine phenols as radioprotective agents |
| AU660325B2 (en) * | 1991-10-11 | 1995-06-22 | Eisai Co. Ltd. | Anti-endotoxin compounds and related molecules and methods |
| US5530113A (en) * | 1991-10-11 | 1996-06-25 | Eisai Co., Ltd. | Anti-endotoxin compounds |
| US6218166B1 (en) | 1994-12-09 | 2001-04-17 | John Wayne Cancer Institute | Adjuvant incorporation into antigen carrying cells: compositions and methods |
| US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| AU2007354917B2 (en) | 2006-09-26 | 2013-06-06 | Access To Advanced Health Institute | Vaccine composition containing synthetic adjuvant |
| TWI494125B (zh) | 2009-06-05 | 2015-08-01 | Infectious Disease Res Inst | 合成的葡萄吡喃糖基脂質佐劑 |
| NZ616304A (en) | 2011-04-08 | 2016-01-29 | Immune Design Corp | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
| AU2013262691B2 (en) | 2012-05-16 | 2018-12-20 | Immune Design Corp. | Vaccines for HSV-2 |
| WO2017039751A1 (en) | 2015-08-28 | 2017-03-09 | Bioincept, Llc | Mutant peptides and methods of treating subjects using the same |
| SG11201508092YA (en) | 2013-04-18 | 2015-10-29 | Immune Design Corp | Gla monotherapy for use in cancer treatment |
| US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
| CA2961375A1 (en) * | 2014-09-16 | 2016-03-24 | Bioincept, Llc | Compositions and methods for treating acute radiation syndrome |
| EP3341006A4 (en) | 2015-08-28 | 2019-03-13 | BioIncept LLC | COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE |
| KR101909660B1 (ko) * | 2017-07-06 | 2018-10-18 | 이보미 | 안경알 자판기 서비스 제공 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1188519A (en) * | 1966-10-27 | 1970-04-15 | Wellcome Found | Method for the Purification of Lipopolysaccharides |
| US4435386A (en) * | 1982-05-26 | 1984-03-06 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4436728A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| CA1225592A (en) * | 1983-08-26 | 1987-08-18 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
-
1984
- 1984-07-12 US US06/630,013 patent/US4629722A/en not_active Expired - Lifetime
-
1985
- 1985-07-09 NZ NZ212691A patent/NZ212691A/en unknown
- 1985-07-10 AU AU44758/85A patent/AU556971B2/en not_active Ceased
- 1985-07-11 NL NL8501995A patent/NL8501995A/nl not_active Application Discontinuation
- 1985-07-11 FR FR8510629A patent/FR2567403A1/fr not_active Withdrawn
- 1985-07-11 GB GB08517545A patent/GB2161381B/en not_active Expired
- 1985-07-11 ZA ZA855243A patent/ZA855243B/xx unknown
- 1985-07-12 DE DE19853524992 patent/DE3524992A1/de active Granted
- 1985-07-12 BE BE0/215338A patent/BE902875A/fr not_active IP Right Cessation
- 1985-07-12 CH CH3039/85A patent/CH665355A5/de not_active IP Right Cessation
- 1985-07-12 DE DE3546592A patent/DE3546592C2/de not_active Expired
- 1985-07-12 IT IT8548347A patent/IT1214671B/it active
- 1985-07-12 KR KR1019850004992A patent/KR880000191B1/ko not_active Expired
- 1985-07-12 IL IL75789A patent/IL75789A/xx unknown
- 1985-07-12 JP JP60152571A patent/JPS6193123A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB2161381A (en) | 1986-01-15 |
| BE902875A (fr) | 1985-11-04 |
| DE3546592C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1988-06-01 |
| IL75789A0 (en) | 1985-11-29 |
| US4629722A (en) | 1986-12-16 |
| AU4475885A (en) | 1986-01-16 |
| FR2567403A1 (fr) | 1986-01-17 |
| IL75789A (en) | 1990-04-29 |
| AU556971B2 (en) | 1986-11-27 |
| KR860000867A (ko) | 1986-02-20 |
| NL8501995A (nl) | 1986-02-03 |
| NZ212691A (en) | 1988-02-12 |
| IT8548347A0 (it) | 1985-07-12 |
| GB8517545D0 (en) | 1985-08-14 |
| KR880000191B1 (ko) | 1988-03-12 |
| IT1214671B (it) | 1990-01-18 |
| JPS6234733B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1987-07-28 |
| GB2161381B (en) | 1988-01-13 |
| DE3524992C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1988-05-11 |
| ZA855243B (en) | 1986-02-26 |
| JPS6193123A (ja) | 1986-05-12 |
| DE3524992A1 (de) | 1986-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH665355A5 (de) | Pharmazeutische zusammensetzung. | |
| DE2934069C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE69425826T2 (de) | Medikament zum schutz vor neurologischen schäden | |
| DE69420776T2 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
| CH654212A5 (de) | Zubereitung zur steigerung der therapeutischen wirkung eines antitumormittels und diese zubereitung enthaltende antitumor-zubereitung. | |
| DE69511448T2 (de) | Verwendung von Phosphorsäurediester-Verbindungen zur Unterdrückung von Krebsmetastasen in der Leber | |
| EP0236390B1 (de) | Mittel gegen multiple sklerose | |
| DE3786304T2 (de) | Immunostimulierende Arzneimittel. | |
| DE3916417C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE3418820A1 (de) | Arzneimittel fuer verdauungsgeschwuer | |
| DE2919514C2 (de) | 1-(2,3-Di-n-alkoxy-1-propyl)-und 1-(1,3-Di-n-alkoxy-2-propyl)-4-aminomethyl-4-phenyl-piperidine und diese enthaltende Arzneimittel | |
| DE3000139A1 (de) | Die verwendung von glyzerinphosphorylderivaten in der therapie der dislipaemie, der hepatitis und vergleichgeeignete pharmazeutische kompositionen | |
| DE2655690A1 (de) | Arzneimittelzubereitungen | |
| DE69328102T2 (de) | Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren | |
| DE69715895T2 (de) | Antimalariamittel mit cis-kondensierten zyklopenteno-1,2,4-trioxanderivate | |
| DE2445679C3 (de) | Stimulierung der Immunität | |
| DE3440621A1 (de) | Pharmazeutische zusammensetzung zur bekaempfung von vireninfektionen und deren verwendung | |
| DE2528460A1 (de) | Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans | |
| AT408719B (de) | Mittel zur behandlung von hepatitis c | |
| DE69527205T2 (de) | Arzneimittel gegen endotoxinschock und dadurch ausgelöstes multiples organversagen | |
| DE2610426C2 (de) | Verwendung eines OEP als Wirkstoff enthaltenden Impfstoffes zur Bekämpfung der durch Pseudomonas aeruginosa hervorgerufenen Pneumonitis der Nerze | |
| DE2314387C3 (de) | Arzneimittel zur Behandlung bösartiger Neubildungen | |
| DE3643001C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE3141970A1 (de) | Arzneimittel zur behandlung der durch den virus der herpes-gruppe erzeugten erkrankungen | |
| DD232432A5 (de) | Verfahren zur herstellung des wirkstoffes eines immunomodulator-medikamentes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |